Inflammatory, Cardiac, and Lipid-Related Biomarkers in Relation to Residual MACE Risk in the REPRIEVE Trial.
Saved in:
| Title: | Inflammatory, Cardiac, and Lipid-Related Biomarkers in Relation to Residual MACE Risk in the REPRIEVE Trial. |
|---|---|
| Authors: | Grinspoon SK; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, USA. Electronic address: sgrinspoon@mgh.harvard.edu., DeFilippi C; Division of Cardiology and Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Umbleja T; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, USA., McCallum S; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, USA., Christenson RH; Division of Cardiology and Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA., Chu SM; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, USA., Lu AB; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, USA., Burdo TH; Department of Medicine, Rutgers Institute of Translational Medicine and Science, Robert Wood Johnson Medical School, Rutgers, The University of New Jersey, New Brunswick, New Jersey, USA., Aberg JA; Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, USA., Fichtenbaum CJ; Division of Infectious Diseases, University of Cincinnati College of Medicine, Cincinnati, USA., Bloomfield GS; Department of Medicine, Duke Global Health Institute and Duke Clinical Research, Duke University School of Medicine, Durham, USA., Malvestutto CD; Division of Infectious Diseases, Ohio State University Medical Center, Columbus, USA., Currier JS; Division of Infectious Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, USA., Lu MT; Cardiovascular Imaging Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, USA., Zanni MV; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, USA., Douglas PS; Duke Clinical Research Institute, Duke University School of Medicine, Durham, USA., Ribaudo HJ; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, USA. |
| Source: | JACC. Advances [JACC Adv] 2026 Jul 10; Vol. 5 (8), pp. 102984. Date of Electronic Publication: 2026 Jul 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918419284106676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2772-963X (Electronic) Linking ISSN: 2772963X NLM ISO Abbreviation: JACC Adv |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42431097 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Inflammatory, Cardiac, and Lipid-Related Biomarkers in Relation to Residual MACE Risk in the REPRIEVE Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Grinspoon+SK%22">Grinspoon SK</searchLink>; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, USA. Electronic address: sgrinspoon@mgh.harvard.edu.<br /><searchLink fieldCode="AU" term="%22DeFilippi+C%22">DeFilippi C</searchLink>; Division of Cardiology and Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Umbleja+T%22">Umbleja T</searchLink>; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, USA.<br /><searchLink fieldCode="AU" term="%22McCallum+S%22">McCallum S</searchLink>; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Christenson+RH%22">Christenson RH</searchLink>; Division of Cardiology and Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Chu+SM%22">Chu SM</searchLink>; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Lu+AB%22">Lu AB</searchLink>; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Burdo+TH%22">Burdo TH</searchLink>; Department of Medicine, Rutgers Institute of Translational Medicine and Science, Robert Wood Johnson Medical School, Rutgers, The University of New Jersey, New Brunswick, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Aberg+JA%22">Aberg JA</searchLink>; Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, USA.<br /><searchLink fieldCode="AU" term="%22Fichtenbaum+CJ%22">Fichtenbaum CJ</searchLink>; Division of Infectious Diseases, University of Cincinnati College of Medicine, Cincinnati, USA.<br /><searchLink fieldCode="AU" term="%22Bloomfield+GS%22">Bloomfield GS</searchLink>; Department of Medicine, Duke Global Health Institute and Duke Clinical Research, Duke University School of Medicine, Durham, USA.<br /><searchLink fieldCode="AU" term="%22Malvestutto+CD%22">Malvestutto CD</searchLink>; Division of Infectious Diseases, Ohio State University Medical Center, Columbus, USA.<br /><searchLink fieldCode="AU" term="%22Currier+JS%22">Currier JS</searchLink>; Division of Infectious Diseases, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Lu+MT%22">Lu MT</searchLink>; Cardiovascular Imaging Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Zanni+MV%22">Zanni MV</searchLink>; Metabolism Unit, Massachusetts General Hospital and Harvard Medical School, Boston, USA.<br /><searchLink fieldCode="AU" term="%22Douglas+PS%22">Douglas PS</searchLink>; Duke Clinical Research Institute, Duke University School of Medicine, Durham, USA.<br /><searchLink fieldCode="AU" term="%22Ribaudo+HJ%22">Ribaudo HJ</searchLink>; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918419284106676%22">JACC. Advances</searchLink> [JACC Adv] 2026 Jul 10; Vol. 5 (8), pp. 102984. <i>Date of Electronic Publication: </i>2026 Jul 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918419284106676 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2772-963X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222772963X%22">2772963X </searchLink><i>NLM ISO Abbreviation: </i>JACC Adv |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42431097 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jacadv.2026.102984 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 102984 Titles: – TitleFull: Inflammatory, Cardiac, and Lipid-Related Biomarkers in Relation to Residual MACE Risk in the REPRIEVE Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Grinspoon SK – PersonEntity: Name: NameFull: DeFilippi C – PersonEntity: Name: NameFull: Umbleja T – PersonEntity: Name: NameFull: McCallum S – PersonEntity: Name: NameFull: Christenson RH – PersonEntity: Name: NameFull: Chu SM – PersonEntity: Name: NameFull: Lu AB – PersonEntity: Name: NameFull: Burdo TH – PersonEntity: Name: NameFull: Aberg JA – PersonEntity: Name: NameFull: Fichtenbaum CJ – PersonEntity: Name: NameFull: Bloomfield GS – PersonEntity: Name: NameFull: Malvestutto CD – PersonEntity: Name: NameFull: Currier JS – PersonEntity: Name: NameFull: Lu MT – PersonEntity: Name: NameFull: Zanni MV – PersonEntity: Name: NameFull: Douglas PS – PersonEntity: Name: NameFull: Ribaudo HJ IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 07 Text: 2026 Jul 10 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2772-963X Numbering: – Type: volume Value: 5 – Type: issue Value: 8 Titles: – TitleFull: JACC. Advances Type: main |
| ResultId | 1 |